Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on NASDAQ
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on NASDAQ
Today’s data is for companies listed on the NASDAQ.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| AMZN | Amazon.com Inc | 2019 | 1636.400000 | 2117.0000 | USD | 10 |
| GOOG | Alphabet Inc | 2019 | 1115.130000 | 1363.3330 | USD | 9 |
| GOOGL | Alphabet Inc | 2019 | 1122.010000 | 1363.3330 | USD | 9 |
| BKNG | Booking Holdings Inc | 2019 | 1915.730000 | 2195.0000 | USD | 5 |
| ILMN | Illumina Inc | 2019 | 301.210000 | 350.0000 | USD | 3 |
| EQIX | Equinix Inc | 2019 | 425.840000 | 483.0000 | USD | 3 |
| IDXX | IDEXX Laboratories Inc | 2019 | 207.740000 | 252.0000 | USD | 2 |
| IAC | IAC/InterActiveCorp | 2019 | 213.500000 | 259.6000 | USD | 5 |
| FANG | Diamondback Energy Inc | 2019 | 105.510000 | 149.6000 | USD | 5 |
| SIVB | SVB Financial Group | 2019 | 245.090000 | 298.3333 | USD | 3 |
| SRPT | Sarepta Therapeutics Inc | 2019 | 140.040000 | 200.8000 | USD | 5 |
| TLRY | Tilray Inc | 2019 | 78.800000 | 200.0000 | USD | 1 |
| SAGE | Sage Therapeutics Inc | 2019 | 152.760000 | 213.3333 | USD | 3 |
| RGLD | Royal Gold Inc | 2019 | 89.450000 | 137.4125 | CAD | 2 |
| GBT | Global Blood Therapeutics Inc | 2019 | 53.120000 | 109.3333 | USD | 3 |
| ICPT | Intercept Pharmaceuticals Inc | 2019 | 92.760000 | 168.2000 | USD | 5 |
| LGND | Ligand Pharmaceuticals Inc | 2019 | 123.830000 | 238.0000 | USD | 2 |
| MDGL | Madrigal Pharmaceuticals Inc | 2019 | 134.490000 | 301.6667 | USD | 3 |
| ANAB | AnaptysBio Inc | 2019 | 69.870000 | 123.2500 | USD | 4 |
| MSTR | MicroStrategy Inc | 2019 | 141.800000 | 200.0000 | USD | 1 |
| GTHX | G1 Therapeutics Inc | 2019 | 19.310000 | 75.0000 | USD | 1 |
| ALBO | Albireo Pharma Inc | 2019 | 26.770000 | 86.0000 | USD | 1 |
| ACRS | Aclaris Therapeutics Inc | 2019 | 6.460000 | 50.0000 | USD | 1 |
| MLNT | Melinta Therapeutics Inc | 2019 | 5.340000 | 70.0000 | USD | 2 |
| CATB | Catabasis Pharmaceuticals Inc | 2019 | 4.970000 | 77.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
GOOG:NAS Alphabet
https://www.abc.xyz
Alphabet has 98771 employees and is headquartered in United States.
Alphabet Inc is a provider of internet content products and portals. Its suite of brands includes Search, Android, YouTube, Apps, Maps & Ads.
IDXX:NAS IDEXX Laboratories
http://www.idexx.com
IDEXX Laboratories has 8377 employees and is headquartered in United States.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.